Formamide

Formamide

SCHEMBL26614879

CC1CC(=O)CCN1C.NC=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20436910 0.90
SCHEMBL167424 0.90
Tert-Butyl Formate SCHEMBL28044015 0.80 TDP1 (0.41)
SCHEMBL28311545 0.69
Formamide SCHEMBL1934585 0.69 CHRM2 (0.34)
Formamide SCHEMBL14779600 0.68
SCHEMBL13465078 0.68
SCHEMBL10076030 0.68
Formamide SCHEMBL6387852 0.67 CHRM2 (0.33)
SCHEMBL22193773 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117157299-B Tricyclic heterocyclic derivative, composition and application thereof 北京丹擎医药科技有限公司 2024-05-28 CN disclosed
US-20240140954-A1 TRICYCLIC HETEROCYCLIC DERIVATIVES, COMPOSITIONS AND USES THEREOF DANATLAS PHARMACEUTICALS CO., LTD. (CN) 2024-05-02 US disclosed
CN-117157299-A Tricyclic heterocyclic derivative, composition and application thereof 北京丹擎医药科技有限公司 2023-12-01 CN disclosed
WO-2023208092-A1 TRICYCLIC HETEROCYCLIC DERIVATIVES, COMPOSITIONS AND USES THEREOF DANATLAS PHARMACEUTICALS CO., LTD. (CN) 2023-11-02 WO disclosed